HCPi Scorecard for

Makhsida, Nawras

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism

Endocrinology


Sphere of Influence
4 of 10 
Payments Received (2019)
$229,627
Spend to Benefit Percentage
58%
HCPI Specialty Rank
20 out of 57,510
Profile
Nawras Makhsida
1390 U.S. Highway 61
Suite 2100
Festus, MO 63028
Website
 636-933-8880
University of Damascus
Graduated 2003
Medical Doctor
Primary Calling Location
Payments Received (2019)
Affiliations
Name City State
Payments Received (2019)
Company Type Payments
Companion Medical, Inc.GENERAL$40
Salix Pharmaceuticals, A Division Of Bausch Health Us, LlcGENERAL$19
Radius Health, Inc.GENERAL$42
Mannkind CorporationGENERAL$16
Regeneron Healthcare Solutions, Inc.GENERAL$65
Antares Pharma, Inc.GENERAL$13
Shire North American Group IncGENERAL$57
Abbott LaboratoriesGENERAL$103
Dexcom, Inc.GENERAL$51
Medtronic Minimed, Inc.GENERAL$233
Amarin Pharma Inc.GENERAL$123
Becton, Dickinson And CompanyGENERAL$42
Insulet CorporationGENERAL$237
Kowa Pharmaceuticals America, Inc.GENERAL$31
Boehringer Ingelheim Pharmaceuticals, Inc.GENERAL$21,767
Janssen Pharmaceuticals, IncGENERAL$115
Abbvie, Inc.GENERAL$65
Amgen Inc.GENERAL$217
Astrazeneca Pharmaceuticals LpGENERAL$193
Novo Nordisk IncGENERAL$67,888
Sanofi-aventis U.s. LlcGENERAL$40,891
Lilly Usa, LlcGENERAL$91,268
Merck Sharp & Dohme CorporationGENERAL$6,153